(Q37788242)

23 August 2017

title

Controversies and challenges in the current management of nasopharyngeal cancer (English)

1 reference

intensity-modulated radiotherapy

23 August 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20836679

11 July 2024

1

Ivan Weng-Keong Tham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20836679

11 July 2024

author name string

Jiade Jay Lu

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20836679

11 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

http://www.future-drugs.com/doi/abs/10.1586/era.10.97

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20836679

http://www.tandfonline.com/doi/pdf/10.1586/era.10.97

11 July 2024

1 reference

Expert Review of Anticancer Therapy

11 July 2024

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1439-1450

1 reference

Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls

23 August 2017

cites work

1 reference

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

21 January 2018

1 reference

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

21 January 2018

1 reference

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

21 January 2018

1 reference

Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma

21 January 2018

1 reference

Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns

21 January 2018

1 reference

Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?

21 January 2018

1 reference

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.

21 January 2018

1 reference

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases

21 January 2018

1 reference

Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma.

21 January 2018

1 reference

Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.

21 January 2018

1 reference

The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging

21 January 2018

1 reference

Inclusion of geometric uncertainties in treatment plan evaluation.

21 January 2018

1 reference

Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans

21 January 2018

1 reference

The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer

21 January 2018

1 reference

Set-up verification using portal imaging; review of current clinical practice

21 January 2018

1 reference

Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?

21 January 2018

1 reference

Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study

21 January 2018

1 reference

Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study

21 January 2018

1 reference

Efficacy of an integrated continuing medical education (CME) and quality improvement (QI) program on radiation oncologist (RO) clinical practice

21 January 2018

1 reference

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

21 January 2018

1 reference

Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy

21 January 2018

1 reference

Radiation dose-volume effects in the larynx and pharynx

21 January 2018

1 reference

Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.

21 January 2018

1 reference

Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy

21 January 2018

1 reference

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

21 January 2018

1 reference

Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer

21 January 2018

1 reference

Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status.

21 January 2018

1 reference

Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

21 January 2018

1 reference

Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy

21 January 2018

1 reference

Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma

21 January 2018

1 reference

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience

21 January 2018

1 reference

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

21 January 2018

1 reference

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china

21 January 2018

1 reference

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

21 January 2018

1 reference

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results

21 January 2018

1 reference

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

21 January 2018

1 reference

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

21 January 2018

1 reference

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

21 January 2018

1 reference

Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

21 January 2018

Nasopharyngeal carcinoma

2

1 reference

11 July 2024

Nasopharyngeal carcinoma

4

1 reference

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

11 July 2024

5

1 reference

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature

11 July 2024

7

1 reference

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

11 July 2024

8

1 reference

Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer

11 July 2024

13

1 reference

Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma

11 July 2024

14

1 reference

Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials

11 July 2024

15

1 reference

Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation

11 July 2024

25

1 reference

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series

11 July 2024

26

1 reference

Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?

11 July 2024

28

1 reference

Temporal changes in IMRT contouring of organs at risk for nasopharyngeal carcinoma - the learning curve blues and a tool that could help

11 July 2024

37

1 reference

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

11 July 2024

39

1 reference

Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma

11 July 2024

55

1 reference

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

11 July 2024

58

1 reference

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function

11 July 2024

59

1 reference

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series

11 July 2024

62

1 reference

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

11 July 2024

67

1 reference

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

11 July 2024

74

1 reference

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

11 July 2024

75

1 reference

11 July 2024

Identifiers

DOI

10.1586/ERA.10.97

1 reference

release_vd44h7whnnbhhlyps2qdws7hmy

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vd44h7whnnbhhlyps2qdws7hmy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference